Literature DB >> 27293870

Bioresorbable vascular scaffolds in patients with acute myocardial infarction: a new step forward to optimized reperfusion?

Fernando Alfonso1, Javier Cuesta1, Teresa Bastante1, Fernando Rivero1, Marcos García-Guimaraes1, Teresa Alvarado1, Amparo Benedicto1, Bernardo Cortese1, Robert Byrne1, Adnan Kastrati1.   

Abstract

Bioresorbable vascular scaffolds (BVS) represent a disruptive technology that has caused a new revolution in interventional cardiology. BVS appear to be particularly appealing in patients presenting with an acute myocardial infarction (MI). The available evidence on the value of BVS implantation in this challenging scenario is very promising but still limited. Results come from preliminary small observational studies, prospective registries that include a control group, and from scarce randomized clinical trials with surrogate mechanistic or angiographic primary end-points. Further studies, powered for clinical endpoints, are required to establish the relative safety and efficacy of BVS vs. new-generation metallic drug-eluting stents (DES) in patients with ST-segment elevation acute MI.

Entities:  

Keywords:  Acute myocardial infarction; bioresorbable vascular scaffolds (BVS); drug-eluting stents (DES); myocardial infarction (MI)

Year:  2016        PMID： 27293870      PMCID： PMC4885952          DOI： 10.21037/jtd.2016.03.75

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


  23 in total

1.  Comparison of everolimus- and biolimus-eluting coronary stents with everolimus-eluting bioresorbable vascular scaffolds.

Authors:  Serban Puricel; Diego Arroyo; Noé Corpataux; Gérard Baeriswyl; Sonja Lehmann; Zacharenia Kallinikou; Olivier Muller; Ludovic Allard; Jean-Christophe Stauffer; Mario Togni; Jean-Jacques Goy; Stéphane Cook
Journal:  J Am Coll Cardiol       Date:  2015-03-03       Impact factor: 24.094

2.  A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods.

Authors:  Patrick W Serruys; John A Ormiston; Yoshinobu Onuma; Evelyn Regar; Nieves Gonzalo; Hector M Garcia-Garcia; Koen Nieman; Nico Bruining; Cécile Dorange; Karine Miquel-Hébert; Susan Veldhof; Mark Webster; Leif Thuesen; Dariusz Dudek
Journal:  Lancet       Date:  2009-03-14       Impact factor: 79.321

3.  Second-generation drug-eluting stents. Moving the field forward.

Authors:  Fernando Alfonso; Cristina Fernandez
Journal:  J Am Coll Cardiol       Date:  2011-04-21       Impact factor: 24.094

4.  Long-term invasive follow-up of the everolimus-eluting bioresorbable vascular scaffold: five-year results of multiple invasive imaging modalities.

Authors:  Cihan Simsek; Antonios Karanasos; Michael Magro; Hector M Garcia-Garcia; Yoshinobu Onuma; Evelyn Regar; Eric Boersma; Patrick W Serruys; Robert J van Geuns
Journal:  EuroIntervention       Date:  2016-01-22       Impact factor: 6.534

5.  Clinical Comparison With Short-Term Follow-Up of Bioresorbable Vascular Scaffold Versus Everolimus-Eluting Stent in Primary Percutaneous Coronary Interventions.

Authors:  Bernardo Cortese; Alfonso Ielasi; Enrico Romagnoli; Attilio Varricchio; Andrea Cuculo; Bruno Loi; Francesco Pisano; Donatella Corrado; Marco Sesana; Luigi La Vecchia; Francesco Summaria; Maurizio Tespili; Pedro Silva Orrego; Gianni Tognoni; Giuseppe Steffenino
Journal:  Am J Cardiol       Date:  2015-06-03       Impact factor: 2.778

6.  Combined use of optical coherence tomography and intravascular ultrasound imaging in patients undergoing coronary interventions for stent thrombosis.

Authors:  Fernando Alfonso; Jaime Dutary; Manuel Paulo; Nieves Gonzalo; Maria J Pérez-Vizcayno; Pilar Jiménez-Quevedo; Javier Escaned; Camino Bañuelos; Rosana Hernández; Carlos Macaya
Journal:  Heart       Date:  2012-08       Impact factor: 5.994

7.  Everolimus-eluting bioresorbable vascular scaffolds for treatment of patients presenting with ST-segment elevation myocardial infarction: BVS STEMI first study.

Authors:  Roberto Diletti; Antonios Karanasos; Takashi Muramatsu; Shimpei Nakatani; Nicolas M Van Mieghem; Yoshinobu Onuma; Sjoerd T Nauta; Yuki Ishibashi; Mattie J Lenzen; Jurgen Ligthart; Carl Schultz; Evelyn Regar; Peter P de Jaegere; Patrick W Serruys; Felix Zijlstra; Robert Jan van Geuns
Journal:  Eur Heart J       Date:  2014-01-06       Impact factor: 29.983

8.  Absorb bioresorbable vascular scaffold versus everolimus-eluting metallic stent in ST-segment elevation myocardial infarction: 1-year results of a propensity score matching comparison: the BVS-EXAMINATION Study (bioresorbable vascular scaffold-a clinical evaluation of everolimus eluting coronary stents in the treatment of patients with ST-segment elevation myocardial infarction).

Authors:  Salvatore Brugaletta; Tommaso Gori; Adrian F Low; Petr Tousek; Eduardo Pinar; Josep Gomez-Lara; Giancarla Scalone; Eberhard Schulz; Mark Y Chan; Viktor Kocka; Jose Hurtado; Juan Antoni Gomez-Hospital; Thomas Münzel; Chi-Hang Lee; Angel Cequier; Mariano Valdés; Petr Widimsky; Patrick W Serruys; Manel Sabaté
Journal:  JACC Cardiovasc Interv       Date:  2015-01       Impact factor: 11.195

9.  Clinical outcomes in patients with ST-segment elevation myocardial infarction treated with everolimus-eluting stents versus bare-metal stents (EXAMINATION): 5-year results of a randomised trial.

Authors:  Manel Sabaté; Salvatore Brugaletta; Angel Cequier; Andrés Iñiguez; Antonio Serra; Pilar Jiménez-Quevedo; Vicente Mainar; Gianluca Campo; Maurizio Tespili; Peter den Heijer; Armando Bethencourt; Nicolás Vazquez; Gerrit Anne van Es; Bianca Backx; Marco Valgimigli; Patrick W Serruys
Journal:  Lancet       Date:  2015-10-29       Impact factor: 79.321

10.  Everolimus-eluting bioresorbable stent vs. durable polymer everolimus-eluting metallic stent in patients with ST-segment elevation myocardial infarction: results of the randomized ABSORB ST-segment elevation myocardial infarction-TROFI II trial.

Authors:  Manel Sabaté; Stephan Windecker; Andres Iñiguez; Lisette Okkels-Jensen; Angel Cequier; Salvatore Brugaletta; Sjoerd H Hofma; Lorenz Räber; Evald Høi Christiansen; Maarten Suttorp; Thomas Pilgrim; Gerrit Anne van Es; Yohei Sotomi; Hector M García-García; Yoshinobu Onuma; Patrick W Serruys
Journal:  Eur Heart J       Date:  2015-09-23       Impact factor: 29.983
View more
  3 in total

1.  Polymeric endovascular strut and lumen detection algorithm for intracoronary optical coherence tomography images.

Authors:  Junedh M Amrute; Lambros S Athanasiou; Farhad Rikhtegar; José M de la Torre Hernández; Tamara García Camarero; Elazer R Edelman
Journal:  J Biomed Opt       Date:  2018-03       Impact factor: 3.170

Review 2.  Thrombotic responses to coronary stents, bioresorbable scaffolds and the Kounis hypersensitivity-associated acute thrombotic syndrome.

Authors:  Nicholas G Kounis; Ioanna Koniari; Anastasios Roumeliotis; Grigorios Tsigkas; George Soufras; Nicholas Grapsas; Periklis Davlouros; George Hahalis
Journal:  J Thorac Dis       Date:  2017-04       Impact factor: 2.895

3.  Plaque Rupture-Induced Myocardial Infarction and Mechanical Circulatory Support in Alpha-Gal Allergy.

Authors:  Sohab S Radwan; Gauravpal Gill; Amre Ghazzal; Awais Malik; Christopher Barnett
Journal:  Case Rep Cardiol       Date:  2020-02-17
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.